HoyleCohen’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $2.95M | Buy |
20,640
+643
| +3% | +$91.8K | 0.22% | 90 |
|
|
2024
Q1 | $2.57M | Buy |
19,997
+10,777
| +117% | +$1.38M | 0.2% | 101 |
|
|
2023
Q4 | $954K | Buy |
9,220
+920
| +11% | +$95.2K | 0.08% | 147 |
|
|
2023
Q3 | $755K | Buy |
8,300
+14
| +0.2% | +$1.27K | 0.07% | 153 |
|
|
2023
Q2 | $670K | Sell |
8,286
-214
| -3% | -$17.3K | 0.06% | 167 |
|
|
2023
Q1 | $676K | Hold |
8,500
| – | – | 0.06% | 159 |
|
|
2022
Q4 | $575K | Sell |
8,500
-30
| -0.4% | -$2.03K | 0.06% | 174 |
|
|
2022
Q3 | $425K | Hold |
8,530
| – | – | 0.05% | 182 |
|
|
2022
Q2 | $475K | Hold |
8,530
| – | – | 0.05% | 181 |
|
|
2022
Q1 | $474K | Hold |
8,530
| – | – | 0.04% | 192 |
|
|
2021
Q4 | $478K | Buy |
8,530
+100
| +1% | +$5.6K | 0.04% | 197 |
|
|
2021
Q3 | $405K | Sell |
8,430
-150
| -2% | -$7.21K | 0.04% | 197 |
|
|
2021
Q2 | $359 | Hold |
8,580
| – | – | 0.03% | 207 |
|
|
2021
Q1 | $289K | Buy |
+8,580
| New | +$289K | 0.03% | 218 |
|